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Glycosylation is a conserved posttranslational modiﬁcation that is found in all eukaryotes, which helps generate proteins with
multiple functions. Our knowledge of glycosylation mainly comes from the investigation of the yeast Saccharomyces cerevisiae
and mammalian cells. However, during the last decade, glycosylation in the human pathogenic mold Aspergillus fumigatus has
drawn signiﬁcant attention. It has been revealed that glycosylation in A. fumigatus is crucial for its growth, cell wall synthesis,
and development and that the process is more complicated than that found in the budding yeast S. cerevisiae. The present paper
implies that the investigation of glycosylation in A. fumigatus is not only vital for elucidating the mechanism of fungal cell wall
synthesis, which will beneﬁt the design of new antifungal therapies, but also helps to understand the role of protein glycosylation
in the development of multicellular eukaryotes. This paper describes the advances in functional analysis of protein glycosylation
in A. fumigatus.
1.Introduction
The Aspergilli are ﬁlamentous fungi, which are multicellular
eukaryotes with a relatively simple life cycle. Over 200
species have been classiﬁed in the genus Aspergillus.M a n y
of them have long been used in food production, industrial
fermentation, and agriculture. On the other hand, a few,
such as A. fumigatus, A. ﬂavus, A. niger, A. nidulans, and
A. terreus, are opportunistic fungal pathogens, causing life-
threatening invasive aspergillosis (IA) in immunosuppressed
patients [1, 2], in which A. fumigatus is the predominant
pathogen [3–5]. The crude mortality for IA is 60–90% and
remains around 29–42% even when treatment is given [6].
The main reasons for patient death are late diagnosis and the
low eﬃciency of the drug therapies available to treat IA.
Thefungalcellwallisaprotectivephysicalbarrieragainst
adverse environmental conditions. The fungal cell wall is a
uniqueorgannotfoundinmammaliancells.Itmaintainscell
shape and provides osmotic protection [7, 8] and has there-
fore been recognized for a long time as an ideal drug target.
Indeed, several cell-wall-targeted drugs, such as echinocan-
dins,caspofungin,micafungin,andanidulafungin,havebeen
introduced as therapies. For example, echinocandins, which
inhibit synthesis of β-1,3-glucan, a crucial component of
the cell wall are eﬀective in the treatment of invasive fungal
infections including IA [9]. Unfortunately, the echinocan-
dins also trigger an increase of chitin [9, 10], which partially
compensatesforthelossof β-1,3-glucanandreducestheeﬃ-
ciencyoftreatmentduetothecomplicatedmechanismofcell
wall biogenesis in A. fumigatus. Therefore, a more profound
understanding of the mechanisms of cell wall biosynthesis in
A. fumigatus would help to improve the eﬃciency of drug
therapies, especially for drugs which target the cell wall.
T h ec e l lw a l lo fA. fumigatus is composed of a unique
β-1,3/1,4-glucan skeleton with chitin and galactomannan
covalently linked to the nonreducing ends of β-1,3-glucan.
The cell wall is mainly coated with GPI proteins, which
contain N- and O-glycans [11, 12]. While there is no doubt
that glycosylation is involved in cell wall organization, the
functional importance of protein glycosylation in cell wall2 International Journal of Microbiology
organization has, until recently, remained poorly under-
stood. However, during the past few years, it has become
increasingly evident that glycosylation is vital for cell wall
synthesis and thus vital for growth and morphology of A.
fumigatus.
Basically, all eukaryotes possess three types of protein
glycosylation, N-glycosylation of asparagine residues, O-gly-
cosylation of threonine and serine residues, and glycosylp-
hosphatidylinositol-anchoring (GPI-anchoring) of the C-te-
rminus of some proteins. Humans lacking individual glyco-
syltransferases suﬀer from severe congenital diseases, known
as carbohydrate-deﬁcient glycoprotein syndromes (CDGs)
[12–14]. Clearly, the sugar components of proteins play a
major role in embryonic and postembryonic development
of humans as well as of all higher eukaryotes. However, the
molecular details leading to CDGs are only vaguely under-
stood. During the past 20 years, the combination of carbo-
hydrate chemistry and biology has developed rapidly. It is
now known that carbohydrates play increasingly important
roles in regulating the development of higher organisms
[15]. However, the mechanism by which carbohydrates play
a role in development and disease is still unclear. Our
knowledge of protein glycosylation comes mainly from
investigation of the model yeast S. cerevisiae and of mam-
malian cells [15]. Although investigation of the model
yeast has been very useful in elucidating the biochemical
features of protein glycosylation at the cellular level, they
cannot reveal the complicated functions of glycosylation
in the development of multicellular eukaryotes. Therefore,
investigation of glycosylation in the multicellular fungus A.
fumigatus not only helps understand the mechanism of cell
wall synthesis in this species but also provides insights into
the role of glycosylation in the development of multicellular
eukaryotes. This paper concentrates on protein glycosylation
in A. fumigatus, which will be discussed with respect
to the enzymatic pathways involved and their functional
importance. Furthermore, the utility of A. fumigatus as a
model for glycosylation during development of multicellular
eukaryotes will be outlined.
2.CellWallOrganizationandItsCompensatory
Mechanism in A. fumigatus
2.1. Cell Wall Organization. T h ec e l lw a l lo fA. fumigatus is
mainly composed of β-1,3-glucans that are highly branched
with β-1,6 linkages. Together they constitute a three-
dimensional network with a large number of nonreducing
ends, to which chitin, galactomannan, and β-1,3/1,4-glucan
are covalently anchored [16] .T h ec e l lw a l li sm a i n l yc o a t e d
with GPI proteins, which contain N- and O-glycans derived
primarily from the process of glycosylation [11, 17]. Glyco-
proteins such as Gel2p and Ecm33p are also involved in cell
wall polysaccharide synthesis. Gel2p is a member of a new
family of GPI-anchored β1,3-glucanosyltransferases. Dele-
tion of gel2 leads to slower growth, abnormal conidiogenesis,
an altered cell wall composition, and reduced virulence [18,
19]. It has been proposed that Gel2p is responsible for the
elongation of β-1,3-glucan side chains of β-1,3/1,6 branched
glucan to provide new nonreducing ends. Ecm33p is also
involved in maintaining proper cell wall architecture though
its function is unknown. Disruption of ECM33 results
in morphogenetic aberrations such as defects in conidial
separation, increase of chitin in conidial cell walls, rapid
conidial germination, and increased virulence [20, 21]. It is
clearthatglycoproteinsaredirectly,asstructuralcomponents
of the cell wall, and indirectly, as enzymes required for
cell wall synthesis, involved in maintaining proper cell wall
architecture in A. fumigatus. However, it remains unclear
how glycosylation aﬀects the function of these proteins.
2.2. Cell Wall Integrity (CWI) Signaling Pathway. Increased
chitin synthesis has been known as an important compen-
satory response to cell wall stress both in S. cerevisiae and
ﬁlamentous fungi [22–26]. In S. cerevisiae, the cell wall is
required to maintain cell shape, which is essential for the
formation of a bud and hence cell division. The yeast cell
remodels its rigid structure to accommodate cell expansion
during vegetative proliferation, mating pheromone-induced
morphogenesis, and nutrient-driven ﬁlamentation through
the cell wall integrity (CWI) signaling pathway. Cell wall
defects or damage induces the cells to activate the CWI
pathway to survive, and the compensatory mechanism
characterizedbyanincreasedchitincontentistriggered[27].
The CWI signaling pathway in S. cerevisiae is activated
in response to low osmolarity, thermal stress, or mating
pheromone and polarized growth. It is comprised of a
family of cell surface sensors coupled to the small G-
protein Rho1p, which activates the CWI MAPK cascade via
protein kinase C (Pkc1p). This signaling cascade activates
the expression of genes encoding for cell wall proteins
that stabilize the cell wall. Meanwhile, activated Rho1p also
activates a set of additional eﬀectors such as Bni1p and
Bnr1p formin proteins, Skn7p transcription factor, and the
Sec3p exocyst component, which regulate a diverse set of
processes including β-glucan synthesis at the site of cell wall
remodeling, gene expression related to cell wall biogenesis,
organization of the actin cytoskeleton, and secretory vesicle
targeting to the growth site [28].
Afamilyofcellsurfacesensorsisresponsiblefordetecting
and transmitting the status of the cell wall to Rho1p
[28]. These sensor molecules include Wsc1p (Hcs77p/Slg1p)
[29–31], Wsc2p and Wsc3p [31], and Mid2p and Mtl1p
[32, 33]. Among these cell wall stress sensors, Wsc1p
and Mid2p appear to be the most important and serve a
partially overlapping role in CWI signaling. The extensive
O-mannosylation of Mid2p and Wsc1p is important to
their stability [34]. Reduced O-mannosylation leads to
incorrect proteolytic processing of these proteins, which in
turn results in impaired activation of the PKC1 pathway
and ﬁnally causes cell death in the absence of osmotic
stabilization [35]. More recently, N-glycan is found to be
directly involved in Mid2p sensing. It has been shown that
both the extent of the N-linked glycan and its distance
from the plasma membrane aﬀect Mid2p function. Non-N-
glycosylated Mid2p fails to perceive cell wall challenges [36].
TheseobservationsdemonstratethatN-andO-glycosylation
are important for CWI sensing and thus important for cell
wall biogenesis and polarized growth in yeast.International Journal of Microbiology 3
T h ep r e s e n c eo fA. fumigatus genes encoding for proteins
homologoustotheyeastRho1p,Rho3p,andCdc42psuggests
a similar mechanism for the CWI pathway. Indeed, it has
been recently shown that Afcdc42/CDC42,A f rho1/RHO1,
and Afrho3/RHO3 are highly expressed in the mutant devoid
of Cwh41p (glucosidase I), which suggests an activation of
these genes induced by cell wall damage [37]. Also, increased
expression and activation of the A. fumigatus MpkAp, an
ortholog of the S. cerevisiae Mpk1p, is also induced by cell
wall damage [38, 39]. It is becoming clear that, as in yeast,
defects in cell wall integrity also trigger the CWI MAPK
cascade in A. fumigatus.
On the other hand, in contrast to yeast, little is known
about the cell wall stress sensors in A. fumigatus. In the last
release of the A. fumigatus genomic database (http://www.as-
pergillus.org.uk/indexhome.htm?secure/sequence info/index
.php∼main), only one protein (AFUA 5G09020) is
annotated as a homologue of the Wsc4p, which does not
appear to contribute to CWI signaling in yeast. Therefore,
the A. fumigatus cell wall stress sensor molecule remains to
be identiﬁed and investigated.
3. Importance of Glycosylation in
A. fumigatus
The precursor of all mannose residues found in galac-
tomannan, glycoprotein, and GPI anchor in A. fumigatus
is GDP-mannose. Therefore, its biosynthesis has drawn
specialattention.Inalleukaryotes,theactivationofmannose
initiates from formation of mannose 6-phosphate (Man-6-
P), which occurs by one of two routes: direct phosphory-
lation of mannose by hexokinase or interconversion from
fructose 6-phosphate (Fru-6-P) via phosphomannose iso-
merase(PMI),andthelatterpathwayrequiresthreeenzymes:
PMI, phosphomannomutase (PMM), and GDP-mannose
pyrophosphorylase (GMPP). Fru-6-P is converted to Man-
6-P by PMI, and then Man-6-P is converted to mannose 1-
phosphate (Man-1-P) by PMM. Subsequently, Man-1-P is
ligated with the guanosine 5-triphosphate molecule (GTP)
to form GDP-mannose by Man-1-P guanylyltransferase [40–
63].
The interconversion of Man-6-P and Fru-6-P catalysed
by PMI is the ﬁrst committed step in the synthesis of
Man-containing sugar chains and provides a link between
glucose metabolism and mannosylation. PMI deﬁciency is
the cause of carbohydrate-deﬁcient glycoprotein syndrome
typeIb(CDG-Ib,OMIM602579)inhumans,buttheclinical
symptoms and aberrant glycosylation can be corrected with
dietary mannose supplements [40].
Genes encoding for PMIs have been investigated in
s e v e r a lf u n g a ls p e c i e s ,s u c ha sS. cerevisiae, Candida albicans,
A. nidulans,a n dCryptococcus neoformans [48–51]. The S.
cerevisiaePMIisencodedbythePMI40gene[51].The pmi −
mutant shows a signiﬁcantly reduced growth rate at high
concentrations of mannose. Biochemical and genome-wide
analysisrevealsthatexcessmannoseleadstoanaccumulation
of Man-6-P, which mainly inhibits the activity of phos-
phoglucose isomerase (PGI) and thus represses glycolysis,
protein biosynthesis, and cell wall biogenesis [52].
Table 1: Properties of PMIs from diﬀerent species.
Species MW
(kD)
Km for
Man-6-P
(mM)
Vmax
(μmol/min/mg) Reference
Aspergillus
fumigates 55 1 753 [54]
Saccharomyces
cerevisiae 45 0.65 980 [51]
Escherichia
coli 42 ND ND [41]
Candida
albicans 49 1.24 1200 [42]
human 46.7 0.25 110 [42]
Porcine ND 0.17 140 [42]
Salmonella
typhimurium 42.6 1.34 833.3 [43, 44]
Xanthomonas
campestris 58 2 33.5 [45]
Pseudomonas
aeruginosa 54 3.03 0.83 [46]
Burkholderia
cepacia 55 9.01 21 [47]
ND, not detected.
The A. nidulans manA1 mutant exhibits abnormal
ballooning of hyphal tips and eventually ceases to grow
[53]. Disrupted MAN1 mutant of C. neoformans leads to
poor capsule formation, reduced polysaccharide secretion,
morphological abnormalities, and attenuated virulence [50].
In A. fumigatus, PMI activity is essential for viability and
plays a central regulatory role in both glycosylation and
energy production. Deletion of the A. fumigatus pmi1 gene
leads to uncoupling of the link between energy production
and glycosylation and accumulation of Man-6-P, which
then results in defects in cell wall integrity, conidiation,
and morphology [54]. Although extracellular mannose can
rescue the growth of PMI deﬁcient mutants in A. fumigatus,
both lower and higher concentrations of mannose lead to a
reduction in the levels of α-glucan in the cell wall and an
accumulation of Man-6-P [54]. The phenotypes associated
with the mutant under mannose starvation are mainly due
to an insuﬃcient supply of GDP-Man required for cell wall
synthesis. The abnormal morphology associated with the
Δpmi1 mutant under mannose-replete conditions is mainly
ascribed to an accumulation of Man-6-P, which cannot
eﬃciently enter glycolysis, instead becoming trapped in a
cycle of dephosphorylation and rephosphorylation resulting
in depletion of intracellular ATP. It should be pointed out
that the PMI in A. fumigatus mainly catalyzes the conversion
of Fru-6-P to Man-6-P, and its binding aﬃnity for Man-6-P
is similar to that of yeasts but diﬀerent from the ones from
bacteria or animals (Table 1). This suggests that it may be
possible to design a speciﬁc inhibitor for fungal PMIs [54].
GMPP is the ﬁnal enzyme in the pathway generating
GDP-mannose. Several GMPPs have been identiﬁed and
characterized in diﬀerent species [55–59]. In S. cerevisiae and
C. albicans, GMPP is essential [60, 61], while in Leishmania4 International Journal of Microbiology
mexicanaGMPPisnotrequiredforviability[62].Repression
of GMPP in yeast leads to pleiotropic phenotypes including
cell lysis, failure of cell separation, impaired budding and
hyphal switching, clumping and ﬂocculation, and cell wall
defects [61]. Repression of expression of A. fumigatus GMPP
srb1, a homologue of yeast SRB1/PSA1/VIG9,l e a d st oh yp h a l
lysis, a defective cell wall, impaired polarity maintenance,
and branching site selection, as well as rapid germination
and reduced conidiation. In contrast to yeast, inducible
repression of srb1 expression in A. fumigatus does aﬀect the
ability to direct polarity establishment and septation [63].
These reports imply that mannose activation is speciﬁ-
callycrucialforthesynthesisandorganizationofthecellwall
and thus essential for survival of fungal species. This further
suggests that glycosylation is essential for the viability of
pathogenicfungalspeciessuchasA.fumigates,andinhibitors
that speciﬁcally block mannose activation in fungi may be
potential drugs to treat fungal infections.
4. Biosynthesis andFunctionof
N-GlycosylationinA. fumigatus
N-glycosylated proteins contain oligosaccharides that are N-
glycosidically linked to the γ-amido group of asparagine.
This type of glycoprotein has been intensively studied in
many model systems from yeast to human cells with respect
to their structure, biosynthesis, and function [15]. It has
been shown that the formation of the highly variable N-
linked oligosaccharides is initiated by the assembly of a
lipid-linked oligosaccharide Glc3Man9GlcNAc2-PP-Dol by a
series of glycosyltransferases located on the cytoplasmic and
luminal faces of the ER membrane. The most complete
understanding of biosynthesis of the lipid bound precursor
has been obtained from S. cerevisiae and from mammals.
As far as it is known, the corresponding reactions proceed
almost identically in other eukaryotes [15].
Subsequently, the Dol-PP-linked Glc3Man9GlcNAc2 is
transferred as a whole to an asparagine residue within an
N-X-T/S consensus sequence of a nascent peptide, which is
catalyzed by the oligosaccharyltransferase (OST), and then
the N-glycosylated proteins are modiﬁed in a species-speciﬁc
mannerandtransferredthroughthesecretorypathwaytothe
cell surface where they either get exported or anchored to the
plasma membrane, to the extracellular matrix, or to the cell
wall (Figure 1).
4.1. Initiation of N-Glycosylation. OST is a membrane
complex consisting of several subunits. In S. cerevisiae, the
OST complex consists of at least eight diﬀerent subunits,
including Ost1p, Ost2p, Wbp1, Stt3p, Swp1p, Ost4p, Ost5p,
and Ost3p/Ost6p [64–67]. Although the function of each
subunit is still unclear, Stt3p is believed to be the catalytic
subunit [68–70], and its homologues are found in almost
all eukaryotes [71]. The S. cerevisiae STT3 is an essential
gene [72, 73]. It appears that the A. fumigatus stt3 is also
essential as no viable knockout mutant has been recovered
[39]. Repression of the stt3 gene in A. fumigatus leads to
a severe retardation of growth and a slight defect in cell
wall integrity [39]. Further analysis shows that repression
of stt3 upregulates expression of the genes responsible for
glucan and chitin synthesis, especially gel1, gel2, fskA, chsE,
and chsG. Indeed, an increase of cell wall mannoprotein and
chitin was observed following repression of the stt3 gene.
However, this upregulation of chitin is not accompanied by
an activation of the MpkA kinase. Indeed, only the unfolded
protein response (UPR) is induced. As the UPR has been
shown to be involved in CWI signaling in A. fumigatus [74],
it is likely that UPR, instead of the MpkA-dependent CWI
signaling pathway, is the major compensatory mechanism
induced by repression of the N-glycosylation in A. fumigatus
[39].
4.2. N-Glycan Processing and Protein Folding Quality Control
in ER. Once Glc3Man9GlcNAc2 is transferred to proteins,
the N-glycan is processed sequentially in the ER and Golgi.
N-Glycan processing is initiated by the removal of the glu-
cose residues catalyzed by ER glucosidase I and glucosidase
II.
In mammalian cells, N-linked glycan plays a decisive
role as a quality control (QC) of the folding of secretory
proteins, which is composed of calnexin, calreticulin, UDP-
glucose:glycoprotein glucosyltransferase (GT) and glucosi-
dase II (GII) and is essential for cellular survival [75–77].
N-glycans initially serve to increase the hydrophilicity of
the as-yet-unstructured nascent polypeptides. Subsequently,
the two outermost glucose residues of the N-glycan are
removed by the sequential action of glucosidase I (GI) and
GII to the monoglucosylated form, which is recognized
and bound by calnexin, a type I ER membrane lectin, and
calreticulin, its soluble relative. For many glycoproteins, the
interaction with calnexin or calreticulin slows down the rate
of folding but increases eﬃciency. GII-catalyzed removal
of the third glucose residue follows the dissociation of
folding substrates from calnexin and is required for release
of native polypeptides from the ER and transport to their
ﬁnaldestination.ThefoldingsensorGTaddsbackaterminal
glucose to promote reassociation of nonnative polypeptides
releasedfromcalnexin,thusprolongingtheirretentioninthe
ER folding environment. Cycles of de-/reglucosylation might
be protracted until the polypeptide released from calnexin
fulﬁlls quality control requirements. When correct folding
is not achieved, an ER-speciﬁc N-glycan-dependent pathway
of degradation removes the misfolded proteins. When N-
glycosylation is inhibited, the most commonly observed
eﬀect is the generation of misfolded, aggregated proteins that
fail to reach a functional state [75, 76].
Before entering the QC system, the outermost glucose
residue of the N-glycan is trimmed by ER glucosidase I
[78]. A human inherited glucosidase I deﬁciency has been
reported to result in neonatal birth with severe generalized
hypotonia and dysmorphic features [79].
Unlike mammalian cells, S. cerevisiae lacks a calnexin
cycle and GT and only has an eﬀective mannosidase I-depe-
ndent ERAD system [80, 81]. The yeast glucosidase I
(Cwh1p) is encoded by the CWH41 gene [82]. Mutational
defects in the CWH41 gene cause severe and selective
instability of glycoprotein Kre6p, a putative Golgi glucan
synthase required for β-l,6-glucan synthesis [23, 83, 84].International Journal of Microbiology 5
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Figure 1: Biosynthesis of the lipid-bound oligosaccharide and transfer of the oligosaccharide to the nascent polypeptide in the endoplasmic
reticulum of S. cerevisiae.The identiﬁed ALG genes for the respective glycosylation reactions are indicated. Synthesis starts at the cytoplasmic
face with UDP-GlcNAc and GDP-Man as donors. The Man5GlcNAc2-PP-Dol is then transferred to the luminal side with the help of Rft1
and elongated to the full-length lipid-linked oligosaccharide Glc3Man9GlcNAc2-PP-Dol by using Dol-P-Man and Dol-P-Glc as donors. The
oligosaccharide is subsequently transferred to the γ-amido group of the asparagine residues within the consensus sequence Asn-X-Ser/Thr
of nascent secretory proteins. This reaction is catalyzed by the oligosaccharyltransferase (OST) complex.
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Figure 2: N-glycan-dependent quality control of protein folding in
A. fumigatus.I nA. fumigatus, the N-glycan-dependent QC system
is composed of calnexin, UDP-glucose: glycoprotein glucosyltrans-
ferase (GT) and glucosidase II (GII).
Some ﬁlamentous fungi have been proposed to pos-
sess N-glycan-dependent QC of glycoprotein folding based
on fungal genome sequence data [85]. Recently, evidence
that ﬁlamentous fungi possess an N-glycan-dependent QC
system has been reported in A. fumigatus [37, 86]. Indeed,
calnexin (AAS68033), glucosidase II, and GT have been
annotated in the last release of the A. fumigatus genomic
database (Figure 2)[ 87]. Zhang et al. [37] reported that
deletion of the cwh41gene in A.fumigatus results in defective
N-glycan processing of the proteins secreted by A. fumigatus.
Although Afcwh41 is not essential for hyphal growth and
virulence, a severe reduction in conidial formation, abnor-
malities of polar growth and septation, and a temperature-
sensitive deﬁciency of cell wall integrity were documented.
Also, the genes encoding Rho-type GTPases (Rho-type
GTPase/CDC42) were upregulated, which suggests that the
CWI pathway was activated in the mutant [37].
4.3. N-GlycanProces singin the Golgi. Afterprocessing by two
ER α-glucosidases, the N-glycan is further processed by the
action of various α1,2-mannosidases, which can remove one
or more of the four α1,2-linked mannose residues. In mam-
malian cells, Man9GlcNAc2 is converted to Man5GlcNAc2 by
the action of ER and Golgi α-mannosidases, which is the
precursor for complex, hybrid, and high-mannose N-glycans
[88].InS.cerevisiae,aspeciﬁcERα1,2-mannosidaseconverts6 International Journal of Microbiology
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Figure 3: Comparison of N-glycans in yeast, A. fumigates, and mammalian cells. After processing by two ER α-glucosidases, the N-glycan
is further processed by the action of various α1,2-mannosidases. In S. cerevisiae, a speciﬁc ER α1,2-mannosidase converts Man9GlcNAc2
into Man8GlcNAc2, which is elongated in the Golgi to form an outer chain containing up to 200 residues of mannose. In A. fumigatus, the
N-glycans on mature glycoprotein are Man6GlcNAc2. In mammalian cells, Man9GlcNAc2 is converted to Man5GlcNAc2 by the action of ER
and Golgi α-mannosidases, which is the precursor for complex, hybrid, and high-mannose N-glycans.
Man9GlcNAc2 into Man8GlcNAc2, which is elongated in the
Golgitoformanouterchaincontainingupto200residuesof
mannose [89, 90]. A. saitoi and Trichoderma reesei have been
found to produce N-glycan structures containing ﬁve man-
nose units (Man5GlcNAc2), suggesting further processing
of the Man9GlcNAc2 precursor [91, 92]. The N-glycans on
mature secreted glycoprotein produced by A. fumigatus are
Man6GlcNAc2,M a n 7GlcNAc2,a n dM a n 8GlcNAc2,i nw h i c h
Man6GlcNAc2 is the major glycoform [37]. These observa-
tions demonstrate that N-glycan synthesis in ﬁlamentous
fungi seems to diﬀer from that in yeast and is similar to that
in higher eukaryotes (Figure 3). Although small N-glycans
are commonly found on glycoproteins of A. fumigatus,
Hex5−13HexNAc2 glycans on the galactomannoproteins, and
Man5−9GlcNAc2 as well as Galf1Man5−7GlcNAc2 structures
on other secreted glycoproteins have been identiﬁed in A.
fumigatus[93,94].Theenzyme(UDP-Galp mutase)required
to synthesize the requisite UDP-Galf donor has been shown
to be an important factor in biosynthesis of the cell wall
in A. fumigatus [94], while the gene/enzyme responsible for
the transfer of Galf has not been identiﬁed. Recently, the A.
fumigatus Och1, a key mannosyltransferase for synthesis of
elaborated protein N-glycans in yeast, has been identiﬁed.
Deletionoftheoch1generesultsinareductionofsporulation
inthepresenceofhighcalciumconcentrations.Thisevidence
suggests that polymannosylated N-glycans exist in A. fumi-
gatus and certain proteins engaged in sporulation require N-
glycan outer chains to be fully functional [95].
Theα-mannosidaseshavebeenclassiﬁedintotwogroups:
Class I and Class II [102, 120, 121]. Class I α-mannosidases
include ER Man9-mannosidase, endomannosidase, and Gol-
gi mannosidase I. Class II α-mannosidases include the lyso-
somal mannosidases, Golgi mannosidase II, yeast vascular
mannosidase [98, 99], and ER α-mannosidase II [122, 123].
Several Golgi α-mannosidases have been cloned and chara-
cterized from Penicillium citrinum [124, 125],A .s a i t o i[126],
A. oryzae [127],T .r e e s e i[128], and A. nidulans [102, 129].
Theseenzymesareallmonomericwithamolecularweightof
50–60kDa and show the maximal activity in the semiacidic
condition (pH 4–6).
ClassIα-mannosidaseisknowntoplayanimportantrole
in the processing of mannose-containing glycans. In Droso-
phila melanogaster, deletion of the Golgi mannosidase I
(MAS-1) results in viable progeny, and the null organisms
synthesize the same range of oligosaccharides as the wild-
type ones, albeit at diﬀerent ratios [130]. In S. cerevisiae,
disruption of the ER α-mannosidase gene does not pre-
vent outer chain synthesis [96]. In the last release of theInternational Journal of Microbiology 7
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TIGR database (http://www.aspergillus.org.uk/indexhome
.htm?secure/sequence info/index.php∼main)[ 87], nine A.
fumigatus genes are annotated to encode α-mannosidases,
including XP 749038.1, XP 754794.1, XP 751252.1, XP
751819.1, XP 752444.1, XP 752825.1, XP 753592.1, XP
751114.1, and XP 750572.1. Among them, MsdSp (XP
752825.1) has been identiﬁed to encode a Class I α1,
2-mannosidase and acts on Man8GlcNAc2 to produce
Man6GlcNAc2. Deletion of the msdS gene leads to a defect
in N-glycan processing, as well as a reduction of cell wall
components (including α-glucan, β-glucan, mannoprotein,
and chitin) and reduced conidiation. Morphological analysis
reveals abnormal polarity and septation. However, deletion
of the msdS has no eﬀe c to nf u n g a lg r o w t ha n dv i r u l e n c e
[97].
4.4. Degradation of N-Glycan. In mammalian cells, free oli-
gosaccharides (fOS) are generated by OST-mediated hydrol-
ysis of Glc3Man9GlcNAc2-PP-dolichol in the lumen of the
ER or peptide N-glycanase (PNGase)-mediated de-N-
glycosylation of newly synthesized glycoproteins either in
the ER or the cytosol. fOS that are liberated in the lumen
of the ER can be transported into the cytosol, where they
are trimmed by an endo-β-D-N-acetylglucosamine H (endo
H)-likeenzymeandtheα-mannosidaseMan2C1pinorderto
yield an oligosaccharide, Man5GlcNAc, that can be imported
directly into lysosomes to be degraded (Figure 4)[ 122,
123, 131–135]. In humans [136] and cattle [137–139], a
deﬁciency in α-mannosidase results in the lethal disease
mannosidosis, a rare lysosomal storage disease with a
collection of clinical symptoms including progressive mental
retardation,impairedhearing,dysostosismultiplex,immune
defects, elevation of serum and urinary oligosaccharide
levels, and an enlargement of lysosomes in most cell types
resulting from the accumulation of undegraded oligosaccha-
rides.
The rat Man2C1p is involved in oligosaccharide
catabolism of misfolded glycoproteins in the lumen of the
ER which have been retrotranslocated into the cytoplasm
for proteolytic disposal [131–133]. A proteolytically cleaved
version of the rat Man2C1p has been found in the lumen of
the ER where it is believed to be involved in the early stages8 International Journal of Microbiology
of glycoprotein maturation (also called ER α-mannosidase
II) (Figure 4)[ 122, 123].
The yeast cytosolic α-mannosidase Ams1p, a counterpart
of Man2C1p, is also involved in the processing of fOS.
Since the yeast Png1p is mainly localized to the cytosol,
it is proposed that the Png1p-generated fOS may both be
generated and processed in the cytosol [100]. The role
of the yeast Ams1p is to aid in recycling macromolecular
components of the cell under nutrient deprivation [101].
Interestingly, after its synthesis in the cytosol, the Ams1p
is translocated into the vacuole by the cytosol-to-vacuole
targeting pathway [101], which suggests a common feature
shared by the S. cerevisiae Ams1p and its mammalian
counterparts. However, the yeast Ams1p only participates
in recycling or utilizing of oligosaccharide but not in
processing of N-glycan (Figure 4)[ 100]. It should also be
noted that no structural studies have been performed on
the products that can be generated from Man8GlcNAc2 by
Ams1p, and the ultimate fate of such products remains
obscure [135]. On the other hand, two Png1p-independent
fOS pools, Man3GlcNAc2 and Man8GlcNAc2, are also seen in
S. cerevisiae. The pool comprising small fOS (Man3GlcNAc2)
appears to be disposed of by unknown enzymes in the
vacuole. The pool containing mainly Man8GlcNAc2 may be
generatedanddisposedofalongthesecretorypathway[135].
Similarly, A. nidulans α-mannosidase IIC is also pro-
posed to be involved in oligosaccharide catabolism [102].
Both A. nidulans α-mannosidase IIC and S. cerevisiae Ams1p
arenotessentialfornormalcellularfunctionsincedisruption
of these genes has no visible eﬀect on growth or morphology
[98, 99, 102].
In contrast to its counterpart in yeast or A. nidulans, the
A. fumigatus Ams1p is required for normal cellular function.
Deletion of the A. fumigatus ams1 leads to a severe defect
in conidial formation, especially at a higher temperature.
In addition, abnormalities of polarity and septation are
associated with the ΔAfams1 mutant. These results show
that the Afams1 gene is required for morphogenesis and
cellular function in A. fumigatus [103]. The involvement of
the Afams1 gene in polarized growth demonstrates that the
processes involved in fOS regulation are important for A.
fumigatus. It is likely that the Ams1p is involved in cell wall
synthesisandthuspolaritythroughtheCWIpathway.There-
fore, probably the ΔAfams1 mutant could serve as a simple
model to investigate the mechanism of α-mannosidosis.
4.5. Functions of N-Glycosylation in Cell Wall Synthesis, Mor-
phology, and Polarity. Functional analyses of the genes req-
uired for N-glycosylation reveal that protein N-glycosylation
is important for cell wall synthesis, morphogenesis, and
polarized growth in A. fumigatus. 2-D gel analysis reveals
that deletion of the cwh41 gene encoding glucosidase I in A.
fumigatus leads to ER stress, which induces overexpression
of HSP70 and calnexin chaperone and activates the ERAD.
Meanwhile,theproteinsrequiredforactinrearrangementare
found to be underexpressed or missing, which is consistent
with the observation of random localization of actin ﬁbers in
themutant[86].Theseobservations,fortheﬁrsttime,clearly
suggest that N-glycosylation contributes to proper folding
and traﬃcking in A. fumigatus. It appears that proteins
involved in cell wall biosynthesis in A. fumigatus are more
dependent on the N-glycan-dependent folding system. As in
yeast, cell wall defects also trigger the CWI signaling pathway
in A. fumigatus,w h i c ha c t i v a t e sd o w n s t r e a me ﬀectors that
regulate cell wall biogenesis and polarized growth. Zhang
et al. [37, 86] have proposed that the proteins required for
cell wall synthesis or cell wall stress sensing are substrates
of A. fumigatus Cwh41p and require glucose trimming
for their proper localization and function. Misfolding of
these proteins would cause cell wall defects, which then
leads to activation of the ERAD and Rho-type GTPases-
mediated CWI pathway. Moreover, activation of CDC42 in
the CWI pathway also activates SepA, an upstream organizer
of actin ring formation at septation sites, and thus causes
abnormal polarized growth associated with the Δafcwh41
mutant (Figure 5). Although the phenotypes associated with
diﬀerent N-glycosylation mutants vary, the ﬁnding that all
of these mutants exhibit phenotypes associated with cell wall
defects, abnormal polarization, and morphological changes
can all be explained by this proposed model.
Obviously,moreinvestigationsareneededtoidentifyand
characterize all of the proteins aﬀected by N-glycosylation in
A. fumigatus. This information would be key to understand-
ing the complex compensatory mechanisms participating in
cell wall biosynthesis in A. fumigatus,w h i c hw o u l ds e r v ea s
a basis to develop new antifungal therapies, as well as help
to elucidate the molecular mechanism of human diseases
associated with defects in glycosylation.
5. BiosynthesisandFunctionofO-Glycosylation
O-mannose glycosylated proteins were ﬁrst discovered in
yeast and ﬁlamentous fungi, and recently this type of
glycoproteins has also been described in mammals. The
O-mannosylation most likely occurs in all animals, with
the exception of nematodes (e.g., Caenorhabditis elegans); it
is also not detected in plants (Arabidopsis thaliana, Oryza
sativa). However, it has also been discovered in one bacterial
species (Mycobacterium tuberculosis)[ 15]. In mammalian
cells, the inner O-linked mannose is elongated with the ﬁrst
addition of a N-acetylglucosamine and then various sugars
[140]. In the case of yeast, the O-mannose type carbohydrate
chain starts with a serine/threonine-linked mannose, which
is extended to an oligomannose chain. In A. fumigatus, the
O-linked glycans on cell wall mannoproteins are found to
be Glcα1, 6Man, Galfβ1, 6Manα1, 6Man, Galfβ1, 5Galfβ1,
6Manα1, 6Man and Galfβ1, 5[Galfβ1,5]3 Galfβ1, 6Man
[141], while only a single mannose residue was detected
on secreted proteins [113]. A further type of protein O-
glycosylation,inwhichasingleβ-O-linkedGlcNAcresidueis
linked to serine and threonine occurs in animals, plants, and
ﬁlamentous fungi, but not in S. cerevisiae. For this type of
protein modiﬁcation, a considerable number of reviews are
available [142–144]. Therefore, this type of O-glycosylation
is not discussed in this paper.
Protein O-mannosylation is initiated by a family of pro-
tein O-mannosyltransferases (PMTs) that are evolutionarily
c o n s e r v e df r o my e a s tt oh u m a n[ 145, 146]. In S. cerevisiaeInternational Journal of Microbiology 9
β1,6
glucans
β1,3
cwh41
GDP-Man
Asn
Asn
Asn
Mannoproteins
Chitin
Glucan
synthase
Actin
DNA synthesis
Cdc42p
Rho1p SepAp
MpkAp
MAPK
Rsr1p
Glucose
Mannose
N-acetylglucosamine
Sensor
Ergosterol
Figure 5: Proposed model of functions of N-glycosylation in A. fumigatus. Proteins that are required for cell wall synthesis or cell wall stress
sensing require N-glycosylation for their proper folding, localization, and function. Disruption of N-glycosylation in A. fumigatus results in
misfolding and degradation of these proteins, which thus causes cell wall defects and then leads to the activation of the Rho-type GTPases
(Rsr1p/Bud1p-Cdc42p-Rho1p-) mediated CWI pathway to compensate for cell wall defects. Meanwhile activation of the CDC42 in the CWI
pathway also activates SepA, an upstream component of actin rearrangement, leading to abnormalities in polarized growth.
a total of seven PMT family members (ScPmt1–7p) are
present [104, 147], which fall into three major groups of
homology:(i)Pmt1/5/7,(ii)Pmt2/3/6,and(iii)Pmt4.Genes
with signiﬁcant homology to PMTs have been cloned in
humans, mice, and Drosophila [148–150]. Speciﬁc protein
substrates that are O-mannosylated by ScPmt1p, ScPmt2p,
or ScPmt4p have been described in S. cerevisiae [151–153].
In comparison with S. cerevisiae, the PMT family is
less redundant in higher eukaryotes. In Drosophila only
two PMT family members are present (rotated abdomen
and twisted)[ 149, 150] .T h es a m ei st r u ef o rm i c ea n d
humans (POMT1 and POMT2) [148, 150]. Mutations in
human POMT1, a homologue of the yeast Pmt4, cause
Walker-Warburg Syndrome (WWS), which is characterized
byseverecongenitalmusculardystrophy,neuronalmigration
defects,andstructuralabnormalitiesoftheeye[13].Targeted
deletion of Pomt1 in mice results in embryonic lethality
due to defects in the formation of the Reichert’s membrane,
the ﬁrst basement membrane to form in the embryo [154].
Mutations of the Drosophila PMT homologues alter muscle
structures and the alignment of adult cuticle [155].
The PMT family is crucial for viability, cell wall integrity,
and morphogenesis in several fungal species, such as S.
cerevisiae, S. pombe, C. albicans and C. neoformans, A.
nidulans,a n dA. fumigatus [108, 109, 111–115, 145, 156].
In S. cerevisiae, single pmt1 mutants fail to grow in
anaerobic conditions on some media [105]. The pmt1,2,3-
triple mutants grow only in osmotically stabilized medium,
whereas the pmt1,2,4- and pmt2,3,4-triple mutants are not
viableinanyconditions,indicatingthatPMTproteinactivity
is essential in S. cerevisiae, although individual genes are
dispensable [104].
C. albicans contains ﬁve PMT genes. The pmt1 mutants
are viable, but they are defective in undergoing cellular
diﬀerentiation from yeast to a true hyphal growth form
under some conditions [106]. The virulence of the pmt1
null mutant is signiﬁcantly attenuated, which is likely due
to reduced O-glycosylation of the C. albicans adhesin Als1p
[106]. The pmt1,4-double mutants are not viable. The
pmt phenotypes are closely linked to alterations in cell
wall components, including cell wall mannoproteins and
polysaccharides [107].
In S. pombe only one member of each PMT subfamily
is present, namely, oma1+, oma2+,a n doma4+. Deletion of
oma2+,aswellassimultaneousdeletionofoma1+ andoma4+
is lethal. Characterization of the viable S. pombe oma1Da n d
oma4D single mutants shows that reduced O-mannosylation
resultsinabnormalcellwallandseptumformation,therefore10 International Journal of Microbiology
severely aﬀecting cell morphology and cell-cell separation
[108].InC.neoformans,threePMT genesarepresent.Pmt4p
is essential for morphogenesis and virulence [109]. Recently,
Willger et al. showed that PMT2 is an essential gene, and the
double pmt1pmt4 deletion is lethal [110].
Filamentous fungi, such as A. fumigatus, A. nidulans,
Neurospora crassa, and Fusarium gramineum, contain only
three pmt genes that belong to the PMT1, PMT2, and PMT4
subfamilies, respectively [107, 108, 113]. Each of the PMTs
appears to function independently. All single pmt mutants in
A. nidulans are viable but showed reduced growth at elevated
temperatures and defects in morphogenesis [111, 112]. The
double deletion pmtA/pmtC (orthologues of the PMT2 and
PMT4)a n dpmtB/pmtC (orthologues of PMT1 and PMT4)
are synthetically lethal.
Previously, Zhuo et al. have shown that a single deletion
of A. fumigatus pmt1 results in temperature-sensitive phe-
notypes [113]. When the A. fumigatus Δpmt1 mutant was
grown on solid complete medium at 37◦C, no diﬀerence
was found between the mutant and the wild type. A
strongly retarded growth, however, was observed when this
mutant was grown at 42◦Ca n d5 0 ◦C. This temperature-
sensitive phenotype could be complemented by the addition
of 1M sucrose in the media. Further analysis shows that
the mannoprotein, α-glucan, and chitin in the cell wall of
the mutant grown at 37◦C are increased, while β-glucan is
reduced. When the A. fumigatus Δpmt1 mutant was cultured
at 42◦C, the α-glucan was increased, while the β-glucan
was decreased, and the mannoprotein and chitin content
remained unchanged. Moreover, deﬁcient conidiation and
reduced germination have been documented at 42◦C[ 113].
As compared with the S. cerevisiae pmt1 mutants, the A.
fumigatus Δpmt1 mutant, as well as the C. albicans and S.
pombe pmt1 mutants, shows more severe defects in cell wall
integrity. This signiﬁcant phenotype could be explained by
the fewer members of PMT family presented in A. fumigatus,
C. albicans, and S. pombe. However, in a recent study by
Mouyna et al., the A. fumigatus pmt1 mutant does not show
any visible phenotype [115]. In the report by Zhuo et al.,
the pmt1 deletion mutant was constructed by replacement
of the entire coding region of the pmt1 in A. fumigatus strain
CEA17 (pyrG −)w i t hapyrG cassette [113]. Therefore, the
geneticbackgroundofthepmt1nullmutantispyrG + pmt1−,
while in the report by Mouyna et al., the pmt1 mutant was
constructed by transformation of A. fumigatus strain ΔKU80
with a deletion cassette containing the E. coli phleomycin
phosphotransferasegene(PHLE)[115].Therefore,themajor
diﬀerencesmaybeduetothediﬀerentgeneticbackgroundof
the strains used in these two reports.
The single pmt2 or double pmt1pmt4 deletion(s) are
lethal [114, 115]. Fang et al. [114] reported that reduced
expression of pmt2 leads to retarded growth, cell wall defects,
abnormal polarity, and reduced conidiation; however, no
temperature-sensitive growth was found. Interestingly, this
is the ﬁrst time that Pmt2p is revealed to be involved
in polarized growth. These observations suggest that A.
fumigatus Pmt2p is required for cell wall synthesis and
morphogenesis and its function is distinct from that of A.
fumigatus Pmt1p.
Disruption of A. fumigatus pmt4 leads to abnormal
mycelial growth, poor conidiation, and abnormal polarity.
Although an increased sensitivity to echinocandin, a β1,3-
glucan synthase inhibitor, was observed in the A. fumigatus
pmt4 null mutant, glucan synthase activity and β1,3-glucan
contentwerenotaﬀected[115].Incontrasttoitscounterpart
inC.albicans[107],A.fumigatuspmt4isnotrequiredforfull
virulence.
The diﬀerent functions associated with diﬀerent A.
fumigatus PMTs are likely due to their diﬀerent substrate
speciﬁcities. Further investigation of the pmt mutants will be
helpfulforunderstandingtheirmolecularmechanism,which
will not only increase our understanding of the function of
O-mannosylation in A. fumigatus, but also may deepen our
understanding of the molecular basis of the human Walker-
Warburg Syndrome (WWS) which features mutations in
POMT1, a homologue of A. fumigatus Pmt4p, and results
in a failure of polarized growth during neuronal migration
[13].
6. Biosynthesis andFunction of GPI
Anchoring in A. fumigatus
GPI anchoring is a conserved glycosylation process in
eukaryotes, which enables many cell surface proteins such
as cell surface enzymes, receptors, and adhesion molecules
to be covalently anchored to the cell membrane [157]. The
core structure of the GPI anchor consists of a lipid group,
myoinositol, glucosamine, several mannose residues, and a
phosphoethanolamine group, which ultimately connects the
GPI anchor to the protein via an amide bond. Although
the number of mannose groups and the position of side-
chains on the GPI anchors vary widely between species, a
common core structure of EtNMan3GlcN-PI is conserved in
all GPI-anchored proteins found in protozoa, yeast, plants,
and mammals (Figure 6).
GPI anchoring is not essential in mammals at a cellular
level as several GPI-deﬁcient cell lines have been established
[158]. However, an acquired GPI-anchoring deﬁciency in
haematopoietic stem cells causes paroxysmal nocturnal
haemoglobinuria [14], a rare but serious human disease.
Also an overexpression of PIG-P, a protein of unknown
function required for GPI anchor synthesis, has been noted
in fetal Down syndrome brain [159]. In contrast to mam-
mals, GPI anchor synthesis is essential in S. cerevisiae [116].
In S. cerevisiae, many GPI-anchored proteins are known to
be involved in morphogenesis and cell wall organization.
Two types of functions have been assigned to these proteins
depending on their localization [160] .O n et y p ei st h eG P I -
mannoproteins covalently linked to cell wall β-1,6-glucan
which play important biological functions in ﬁlamentation,
mating, ﬂocculation, or adhesion to the external matrix
[161–167]. The second type are the GPI proteins associ-
ated with the plasma membrane which possess enzymatic
activities able to modify cell wall polymers and are involved
in altering cell morphology, such as β-glucanase and β-
glucosyltransferase[168–170].RecentstudiesinA.fumigatus
suggestthatatleastnineGPI-anchoredproteinsarecommon
to ﬁlamentous fungi and yeast. Five of them are homologuesInternational Journal of Microbiology 11
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of putative GPI-anchored yeast proteins that have been
shown to play a role in cell wall morphogenesis [160].
The GPI anchor is assembled at the ER in multiple
steps catalyzed by the concerted actions of approximately
20 proteins [171]. The ﬁrst step of GPI anchor synthesis
is initiated by the transfer of N-acetylglucosamine (Glc-
NAc) from UDP-GlcNAc to phosphatidylinositol (PI), which
is catalyzed by the glycosylphosphatidylinositol-N-acetyl-
glucosaminyltransferase (GPI-GnT) complex. The mam-
malian GPI-GnT complex consists of seven proteins, includ-
ing PIG-A, PIG-H, PIG-C, PIG-P, GPI1, PIG-Y, and DPM2
[172]. All except DPM2 have structural and functional
counterparts in S. cerevisiae, where they are known as Gpi3p,
Gpi15p,Gpi2p,Gpi19p,Gpi1p,andEri1p,respectively[173].
PIG-A/Gpi3p is believed to possess the catalytic domain
becauseGpi3pbindsaphotoactivatableUDP-GlcNAcanalog
and is a member of glycosyltransferase Family 4 of retaining
glycosyltransferases [171]. The roles of the other subunits
in the GPI-GnT complex are as yet unclear, but they may
mediate regulatory interactions.
In yeast, GPI anchoring is essential for viability and plays
an important role in the biosynthesis and organization of the
cell wall. A gpi3 temperature-sensitive mutant is not viable
at 37◦C[ 116, 117]. Similar results have been observed in
the ﬁlamentous fungus N. crassa [118]. In both cases, it is
postulated that the introduction of mutations in GPI3/gpig-
1 genes allows for minimal level of product function and
survival when growing the mutant cells below the restrictive
temperatures. However, the mechanism, by which the defect
in GPI anchoring leads to a lethal phenotype in these two
species, is poorly understood.
It has been shown that A. fumigatus GPI anchors possess
ﬁve mannose residues with a phosphoethanolamine linked
on the ﬁrst three residues [174, 175]. The A. fumigatus pig-
a gene, the homologue of the GPI3/pig-A gene in yeast,
has been investigated [119]. Deletion of Δafpig-a results
in a phenotype characterized by increased cell lysis. Also,
an increased content of β-glucan and mannoprotein was
observed in the mycelial cell wall of the Δafpig-a mutant.
Unlike the temperature-sensitive or conditional lethal phe-
notypeseenintheyeastGPI3mutant,Δafpig-acansurviveat
temperatures from 30◦Ct o5 0 ◦C. Completely blocking GPI
anchor synthesis in A. fumigatus Δafpig-a leads to cell wall
defects, abnormal hyphal growth, rapid conidial germina-
tion, and aberrant conidiation. In vivo assays reveal that the
mutant exhibits reduced virulence in immunocompromised
mice. Therefore, the GPI anchor seems not essential for
viability, but required for cell wall integrity, morphogenesis
and virulence in A. fumigatus. Indeed, this is the ﬁrst report
that a deﬁciency in GPI-anchor synthesis does not lead to
a temperature-sensitive or conditional lethal phenotype in
microbes, which provides an opportunity to identify the
basic function of GPI anchoring in fungi.
7. Outlook
During the past 50 years, proteins and nucleic acids have
dominated the ﬁeld of biology. Carbohydrates remained
very much on the sidelines. Since the late 1980’s, the
enormous advances in the analysis of complex carbohydrates
have enabled us to investigate the structure and function
of carbohydrates, and the ﬁeld has developed enormously.
It is now known that carbohydrates play very important
roles, especially in the regulation of development of higher
organisms. However, the mechanisms by which carbohy-
drates play a role in development and diseases are still12 International Journal of Microbiology
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to the monoglucosylated form, which is bound by calnexin (AFUA 4G12850). For many glycoproteins, the interaction with calnexin
slows down the rate of folding but increases eﬃciency. GII-catalyzed removal of the third glucose residue follows the dissociation
of folding substrates from calnexin and is required for the release of properly folded proteins from the ER and transport to the
Golgi. When correct folding is not achieved, the folding sensor peptide:glucosyltransferase (GT) (AFUA 2G02360) adds back a terminal
glucose to promote reassociation of nonnative polypeptides released from calnexin, thus prolonging their retention in the ER folding
environment. Cycles of de-/reglucosylation might be protracted until the polypeptide released from calnexin fulﬁlls quality control
requirements. Misfolded proteins are removed by an ER-speciﬁc N-glycan-dependent pathway of degradation. Ams1p (AFUA 3G08200)
has been identiﬁed as vacuole α-mannosidase that is involved in degradation of N-glycans. Once the native proteins are released
from calnexin, the N-glycan is further processed by a yet-unknown ER mannosidase to form Man8GlcNAc2. Then N-glycosylated
proteins are transported into the Golgi, where the N-glycan is trimmed by MsdSp (AFUA 1G14560) to yield Man6GlcNAc2. When
N-glycosylation is inhibited in A. fumigatus, the most commonly observed eﬀects are cell wall defects and abnormal polarity, which
are likely due to the generation of misfolded, aggregated proteins that are required for cell wall synthesis. The O-mannosylation is
catalyzed by Pmt1p (AFUA 3G06450), Pmt2p (AFUA 1G07690), and Pmt4p (AFUA 8G04500), which function independently and are
required for cell wall synthesis, thermotolerance, and polarity. Pig-ap (AFUA 1G16950) has been identiﬁed as the catalytic subunit of
the glycosylphosphatidylinositol-N-acetyl-glucosaminyltransferase (GPI-GnT) complex. GPI anchoring is required for cell wall synthesis,
morphology, and virulence.International Journal of Microbiology 13
Table 2: Summary of the fungal genes studied in glycosylation pathways.
Pathway Function Gene Species Phenotypes Reference
PMI40 S. cerevisiae
The pmi− mutant only grows on media with
exogenous mannose. Excess exogenous man-
nose leads to an accumulation of Man-6-P,
which represses glycolysis, protein biosynthesis,
a n dc e l lw a l lb i o g e n e s i s
[52]
Phosphomannose
isomerase (PMI)
MAN1 C.
neoformans
Disrupted MAN1 mutant displays poor capsule
formation, reduced polysaccharide secretion,
morphological abnormalities, and attenuated
virulence
[50]
Mannose
activation manA A. nidulans The manA1 mutant exhibits abnormal balloon-
ing of hyphal tips and eventually ceases to grow. [53]
pmi1 A. fumigatus
Deletion of pmi1 results in defects in cell wall
integrity, conidiation, and morphology. Both
lower and higher concentrations of mannose
lead to a reduction in the levels of α-glucan in
the cell wall and an accumulation of Man-6-P
in the mutant
[54]
GDP-mannose
pyrophosphorylase
(GMPP)
SRB1 S. cerevisiae
Cell lysis, failure of cell separation, impaired
budding and hyphal switching, clumping and
ﬂocculation, and cell wall defects
[61]
srb1 A. fumigatus
Defective cell wall and impaired polarised
growth, as well as rapid germination and
reduced conidiation
[63]
Oligosaccharyltrans-
ferase (OST)
STT3 S. cerevisiae Essential gene [72, 73]
stt3 A. fumigatus
Repression of the stt3 gene leads to a severe
retardation of growth, a slight defect in cell wall
integrity and UPR
[39]
ER Glucosidase I
CWH41 S. cerevisiae
Mutational defects in the CWH41 gene cause
severe and selective instability of glycopro-
tein Kre6p, a putative Golgi glucan synthase
required for β-l, 6-glucan synthesis
[23, 83, 84]
cwh41 A. fumigatus
Deletion of cwh41 leads to severe reduction
in conidial formation, abnormalities of polar
growth, septation and temperature-sensitive
deﬁciency of cell wall integrity.
[37]
N-glycosylation
Golgi mannosidase II
MSDS S. cerevisiae Disruption of t MSDS does not prevent outer
chain synthesis [96]
msdS A. fumigatus
Deletion of msdS gene leads to a defect in
N-glycan processing, as well as a reduction
of cell wall components (including α-glucan,
β-glucan, mannoprotein, and chitin), reduced
conidiation, abnormal polarity, and septation
[97]
Cytosolic/vacuolar
α-mannosidase
AMS1 S. cerevisiae
The Ams1p is involved in recycling macro-
molecular components of the cell under nutri-
ent deprivation. Deletion of AMS1 causes no
visible eﬀect on growth or morphology
[98–101]
ams1 A. nidulans oligosaccharide catabolism; no visible eﬀect on
growth or morphology [102]
ams1 A. fumigatus
Deletion of ams1 leads to a severe defect
in conidial formation (especially at a higher
temperature), abnormalities of polarity, and
septation
[103]14 International Journal of Microbiology
Table 2: Continued.
Pathway Function Gene Species Phenotypes Reference
PMT1
PMT2
PMT3
PMT4
PMT5
PMT6
PMT7
S. cerevisiae
Single pmt1 mutants fail to grow in anaerobic
conditions on some media. The pmt1,2,3-triple
mutants grow only in osmotically stabilized
medium, whereas the pmt1,2,4-and pmt2,3,4-
triple mutants are not viable in any conditions
[104, 105]
O-glycosylation mannosyltransferase
PMT1
PMT2
PMT4
PMT5
PMT6
C. albicans
The pmt1 mutants are viable, but defective
in undergoing cellular diﬀerentiation from
yeast to a true hyphal growth form under
some conditions. The virulence of the pmt1
null mutant is signiﬁcantly attenuated. pmt1,4-
double mutants are not viable. The pmt pheno-
types are closely linked to alterations in cell wall
components,includingcellwallmannoproteins
and polysaccharides
[106, 107]
oma1+,
oma2+
oma4+
S. pombe
Deletion of oma2+, as well as simultaneous
deletion of oma1+ and oma4+, is lethal. The
viable oma1Da n doma4D single mutants show
abnormal cell wall and septum formation
[108]
PMT1
PMT2
PMT4
C.
neoformans
Pmt4p is essential for morphogenesis and viru-
lence.PMT2isanessentialgene,andthedouble
pmt1pmt4 deletion is synthetically lethal
[109, 110]
pmtA
pmtB
pmtC
A. nidulans
All single pmt mutants are viable but show
r e d u c e dg r o w t ha te l e v a t e dt e m p e r a t u r e sa n d
defects in morphogenesis. Double deletion of
pmtA/pmtC and pmtB/pmtC is lethal
[111, 112]
pmt1
pmt2
pmt4
A. fumigatus
Deletion of pmt1 results in temperature- sensi-
tive phenotypes including retarded growth, cell
walldefects,deﬁcientabilityofconidiation,and
reduced germination [113–115]
Single pmt2 or double pmt1pmt4 deletion(s)
are lethal. Repression of pmt2 leads to retarded
gro wth,cellwalldefects,abnormalpolarity ,and
reduced conidiation
Disruption of pmt4 leads to abnormal mycelial
growth, poor conidiation, and abnormal
polarity.
GPI-anchoring
Glycosylphosphatidyl-
inositol-N-acetyl-
glucosaminyltrans-
ferase (GPI-GnT)
GPI3 S. cerevisiae A gpi3 temperature-sensitive mutant is lethal at
37◦C [116, 117]
gpig-1 N. crassa Temperature-sensitive phenotypes [118]
pig-a A. fumigatus
Deletion of pig-a results in a number of
phenotypes including increased cell lysis, cell
wall defects, abnormal hyphal growth, rapid
conidialgermination,aberrantconidiation,and
reduced virulence
[119]
poorly understood. Our knowledge of protein glycosylation
comes mainly from the investigation of S. cerevisiae and
mammalian cells. Although investigations of the model
yeast and mammalian cells have been very useful in elu-
cidating the biochemical features of protein glycosylation,
these investigations at the cellular level cannot reﬂect the
complicated functions of glycosylation in the develop-
ment of multicellular eukaryotes. Therefore, more model
systems have been introduced, such as Caenorhabditis ele-
gans, Drosophila melanogaster, and mice. However, these
model systems are still too complex since deletion of indi-
vidual glycosyltransferase genes in these systems sometimes
leads to fetal death or nonvisible phenotypes. As compared
with S. cerevisiae, C. elegans, D. melanogaster,o rm i c e ,A.
fumigatus seems to be an ideal model for investigation of the
function of glycosylation since A. fumigatus is a multicellularInternational Journal of Microbiology 15
eukaryote with a relative simple life cycle, in which it
undergoes a series of developmental events that require
polarized growth. Recent progress shows that A. fumigatus
has evolved an intact N-glycan-dependent QC system, which
is present in mammalian cells but not in yeast. Disruption of
either processing or degradation of N-glycan in A. fumigatus
leads to phenotypes such as cell wall defects and abnormal
polarity.
Based on investigations of S. cerevisiae and ﬁlamentous
fungi, it is likely that glycosylation ﬁrst evolved to ensure
synthesis of the fungal cell wall and only later did the
N-glycan-dependent QC system evolve to ensure precisely
controlled cell wall synthesis and polarized growth which
are important for multicellular development. However,
this hypothesis is controversial. Recently, based on inves-
tigations of numerous protists and fungi, Banerjee et al.
[85] showed that the N-glycan-dependent QC system is
functional in Entamoeba, Trichomonas, Cryptococcus,a n dS.
pombe, but is not functional in some fungi such as Giardia
and Plasmodium, Theileria, Encephalitozoon, Toxoplasma,
Cryptosporidium,a n dTetrahymena. They proposed that the
N-glycan-dependent QC system was likely present in the
common ancestor of extant eukaryotes and was secondarily
lost from some eukaryotes. For example, the S. cerevisiae
Kre5 is believed to be the GT ortholog that no longer
glucosylates misfolded glycoproteins but is instead thought
to be involved in β-1,6-glucan synthesis [85]. Of course,
the possibility that the S. cerevisiae Kre5 is the ancestor
of GT cannot be excluded. It remains unclear where is
the evolutionary origin of glycosylation, what is the basic
function of glycosylation at the early stages of evolution,
and how glycosylation is regulated. Deﬁnitely, the answers
to these questions will enable us to understand the basic
function and regulation of glycosylation in the development
of multicellular eukaryotes and help to understand more
complex functions in higher eukaryotes. On the other
hand, the investigation of A. fumigatus is also a key to
understanding complex compensatory mechanisms of cell
wall biosynthesis and may provide a new strategy for drug
development.
During the past few years, the framework of the biosyn-
thetic pathways of glycosylation in A. fumigatus has been
delineated. Functional analyses of some of the genes in
this pathway have shown that glycosylation is required for
cell wall synthesis, polarity, morphogenesis, and cellular
function in A. fumigatus (Figure 7 and Table 2). However, a
detailed understanding of this pathway remains unknown,
such as details regarding the synthesis of the N-glycan
precursor, the precise molecular mechanism of N-glycan
processing, QC of protein folding, and modiﬁcation of the
GPI anchor. Moreover, the molecular mechanisms by which
glycosylationplaysaroleinmorphogenesisanddevelopment
of A.fumigatus are vaguely understood. Therefore, the future
direction would be looking for those key proteins that are
aﬀected by glycosylation and identifying the signal trans-
duction pathways that link glycosylation and development,
through genetic, biochemical, cell biological, and proteomic
studies.
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